Detalhe da pesquisa
1.
A case of familial hypocalciuric hypercalcemia type 1 due to CASR p.Pro55Leu mutation.
BMC Endocr Disord
; 22(1): 164, 2022 Jun 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-35733207
2.
Advances in insulin therapy from discovery to ß-cell replacement.
J Diabetes Investig
; 14(1): 15-18, 2023 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-36074333
3.
Graves' Disease with Thymic Hyperplasia: The Response of the Thyroid Function, Thyrotropin Receptor Autoantibody, and Thymic Size to Thiamazole Treatment.
Intern Med
; 61(18): 2753-2757, 2022 Sep 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-35228417
4.
Effects of ChREBP deficiency on adrenal lipogenesis and steroidogenesis.
J Endocrinol
; 248(3): 317-324, 2021 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33538705
5.
Type 1 Diabetes Mellitus and Klinefelter Syndrome.
Intern Med
; 58(2): 259-262, 2019 Jan 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-30146555
6.
Chronic exposure to methylated arsenicals stimulates arsenic excretion pathways and induces arsenic tolerance in rat liver cells.
Toxicol Sci
; 91(1): 70-81, 2006 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-16436460
7.
Evaluation of immunotoxic and immunodisruptive effects of inorganic arsenite on human monocytes/macrophages.
Int Immunopharmacol
; 6(2): 304-15, 2006 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-16459422
8.
Caspase-independent apoptosis induced in rat liver cells by plancitoxin I, the major lethal factor from the crown-of-thorns starfish Acanthaster planci venom.
Toxicon
; 48(8): 1002-10, 2006 Dec 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-16973201
9.
Endocrine disruptive effects of inorganic arsenicals.
Environ Sci
; 13(2): 101-6, 2006.
Artigo
em Inglês
| MEDLINE | ID: mdl-16788561
10.
Evaluation of in vivo acute immunotoxicity of a major organic arsenic compound arsenobetaine in seafood.
Int Immunopharmacol
; 4(2): 179-84, 2004 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-14996409
11.
Evaluation of immunotoxic and immunodisruptive effects of inorganic arsenite on human monocytes/macrophages.
Int Immunopharmacol
; 4(13): 1661-73, 2004 Dec 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-15454118
12.
Acquisition of apoptotic resistance in cadmium-induced malignant transformation: specific perturbation of JNK signal transduction pathway and associated metallothionein overexpression.
Mol Carcinog
; 45(8): 561-71, 2006 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-16568437
13.
Clinical pharmacokinetic study of arsenic trioxide in an acute promyelocytic leukemia (APL) patient: speciation of arsenic metabolites in serum and urine.
Biol Pharm Bull
; 29(5): 1022-7, 2006 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-16651738
14.
Inorganic arsenite alters macrophage generation from human peripheral blood monocytes.
Toxicol Appl Pharmacol
; 203(2): 145-53, 2005 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-15710175
15.
Cytolethality of glutathione conjugates with monomethylarsenic or dimethylarsenic compounds.
Biol Pharm Bull
; 28(10): 1827-32, 2005 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-16204930
16.
The nitric oxide prodrug, V-PYRRO/NO, protects against cadmium toxicity and apoptosis at the cellular level.
Nitric Oxide
; 12(2): 114-20, 2005 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-15740985
17.
Preventive mechanism of cellular glutathione in monomethylarsonic acid-induced cytolethality.
Toxicol Appl Pharmacol
; 206(1): 54-65, 2005 Aug 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-15963344
18.
Acquisition of apoptotic resistance in arsenic-induced malignant transformation: role of the JNK signal transduction pathway.
Carcinogenesis
; 23(1): 151-9, 2002 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-11756236
19.
A major human arsenic metabolite, dimethylarsinic acid, requires reduced glutathione to induce apoptosis.
Chem Res Toxicol
; 15(5): 629-37, 2002 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-12018983
20.
Cellular glutathione prevents cytolethality of monomethylarsonic acid.
Toxicol Appl Pharmacol
; 195(2): 129-41, 2004 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-14998680